Subscribe
shutterstock_1642888921_kira_yan
Kira Yan / Shutterstock.com
22 April 2020Big PharmaSarah Morgan

OECD and Europol issue COVID-19 counterfeits warning

The COVID-19 pandemic is heightening the dangers posed by the global trade in counterfeit pharmaceutical products, according to the  Organisation for Economic Co-operation and Development (OECD) and the  European Union Intellectual Property Office (EUIPO).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.
Africa
US companies hit hardest by fake medicines: EUIPO, OECD
24 March 2020   Companies registered in the US are hit hardest by the trade in counterfeit medicines, which in 2016 reached $4.4 billion, according to a report from the European Union Intellectual Property Office.
Big Pharma
Counterfeiters exploiting COVID-19 outbreak: MHRA
24 March 2020   Counterfeit face masks and unauthorised antiviral medication have been seized under Interpol’s annual Operation Pangea, as criminals seek to take advantage of the COVID-19 pandemic by exploiting demand.


Editor's picks

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

Editor's picks

Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.
Africa
US companies hit hardest by fake medicines: EUIPO, OECD
24 March 2020   Companies registered in the US are hit hardest by the trade in counterfeit medicines, which in 2016 reached $4.4 billion, according to a report from the European Union Intellectual Property Office.
Big Pharma
Counterfeiters exploiting COVID-19 outbreak: MHRA
24 March 2020   Counterfeit face masks and unauthorised antiviral medication have been seized under Interpol’s annual Operation Pangea, as criminals seek to take advantage of the COVID-19 pandemic by exploiting demand.

More on this story

Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.
Africa
US companies hit hardest by fake medicines: EUIPO, OECD
24 March 2020   Companies registered in the US are hit hardest by the trade in counterfeit medicines, which in 2016 reached $4.4 billion, according to a report from the European Union Intellectual Property Office.
Big Pharma
Counterfeiters exploiting COVID-19 outbreak: MHRA
24 March 2020   Counterfeit face masks and unauthorised antiviral medication have been seized under Interpol’s annual Operation Pangea, as criminals seek to take advantage of the COVID-19 pandemic by exploiting demand.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?